These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 31112044)
1. Effect of Macro-Cyclic Bifunctional Chelators DOTA and NODAGA on Radiolabeling and Vatsa R; Shukla J; Kumar S; Chakraboarty S; Dash A; Singh G; Mittal BR Cancer Biother Radiopharm; 2019 Sep; 34(7):427-435. PubMed ID: 31112044 [No Abstract] [Full Text] [Related]
2. Toward realization of 'mix-and-use' approach in ⁶⁸Ga radiopharmacy: preparation, evaluation and preliminary clinical utilization of ⁶⁸Ga-labeled NODAGA-coupled RGD peptide derivative. Chakraborty S; Chakravarty R; Vatsa R; Bhusari P; Sarma HD; Shukla J; Mittal BR; Dash A Nucl Med Biol; 2016 Jan; 43(1):116-123. PubMed ID: 26527030 [TBL] [Abstract][Full Text] [Related]
3. [(68)Ga]FSC-(RGD)3 a trimeric RGD peptide for imaging αvβ3 integrin expression based on a novel siderophore derived chelating scaffold-synthesis and evaluation. Knetsch PA; Zhai C; Rangger C; Blatzer M; Haas H; Kaeopookum P; Haubner R; Decristoforo C Nucl Med Biol; 2015 Feb; 42(2):115-22. PubMed ID: 25459110 [TBL] [Abstract][Full Text] [Related]
4. Novel (64)Cu- and (68)Ga-labeled RGD conjugates show improved PET imaging of α(ν)β(3) integrin expression and facile radiosynthesis. Dumont RA; Deininger F; Haubner R; Maecke HR; Weber WA; Fani M J Nucl Med; 2011 Aug; 52(8):1276-84. PubMed ID: 21764795 [TBL] [Abstract][Full Text] [Related]
5. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers. Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391 [TBL] [Abstract][Full Text] [Related]
6. Mittal S; Sharma R; Mallia MB; Sarma HD Nucl Med Biol; 2021; 96-97():61-67. PubMed ID: 33838524 [TBL] [Abstract][Full Text] [Related]
7. Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers. Shi J; Kim YS; Chakraborty S; Zhou Y; Wang F; Liu S Amino Acids; 2011 Nov; 41(5):1059-70. PubMed ID: 20052508 [TBL] [Abstract][Full Text] [Related]
8. [68Ga]NODAGA-RGD for imaging αvβ3 integrin expression. Knetsch PA; Petrik M; Griessinger CM; Rangger C; Fani M; Kesenheimer C; von Guggenberg E; Pichler BJ; Virgolini I; Decristoforo C; Haubner R Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1303-12. PubMed ID: 21487838 [TBL] [Abstract][Full Text] [Related]
9. [⁶⁸Ga]NS₃-RGD and [⁶⁸Ga] Oxo-DO3A-RGD for imaging α(v)β₃ integrin expression: synthesis, evaluation, and comparison. Knetsch PA; Petrik M; Rangger C; Seidel G; Pietzsch HJ; Virgolini I; Decristoforo C; Haubner R Nucl Med Biol; 2013 Jan; 40(1):65-72. PubMed ID: 23102540 [TBL] [Abstract][Full Text] [Related]
11. The practicality of nanoceria-PAN-based (68)Ge/(68)Ga generator toward preparation of (68)Ga-labeled cyclic RGD dimer as a potential PET radiotracer for tumor imaging. Chakraborty S; Chakravarty R; Sarma HD; Dash A; Pillai MR Cancer Biother Radiopharm; 2013 Feb; 28(1):77-83. PubMed ID: 22967229 [TBL] [Abstract][Full Text] [Related]
12. Comparison of DOTA and NODAGA as chelators for (64)Cu-labeled immunoconjugates. Ghosh SC; Pinkston KL; Robinson H; Harvey BR; Wilganowski N; Gore K; Sevick-Muraca EM; Azhdarinia A Nucl Med Biol; 2015 Feb; 42(2):177-83. PubMed ID: 25457653 [TBL] [Abstract][Full Text] [Related]
13. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors. Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983 [TBL] [Abstract][Full Text] [Related]
14. (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging. Liu Z; Niu G; Shi J; Liu S; Wang F; Liu S; Chen X Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):947-57. PubMed ID: 19159928 [TBL] [Abstract][Full Text] [Related]
16. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related]
17. Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide. Dijkgraaf I; Terry SY; McBride WJ; Goldenberg DM; Laverman P; Franssen GM; Oyen WJ; Boerman OC Contrast Media Mol Imaging; 2013; 8(3):238-45. PubMed ID: 23606427 [TBL] [Abstract][Full Text] [Related]
18. A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of Zhu W; Cheng Y; Jia R; Zhao H; Bai C; Xu J; Yao S; Huo L J Nucl Med; 2021 Oct; 62(10):1398-1405. PubMed ID: 33579804 [No Abstract] [Full Text] [Related]
19. Imaging of α Grönman M; Tarkia M; Kiviniemi T; Halonen P; Kuivanen A; Savunen T; Tolvanen T; Teuho J; Käkelä M; Metsälä O; Pietilä M; Saukko P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A J Transl Med; 2017 Jun; 15(1):144. PubMed ID: 28629432 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of bifunctional chelates for the development of gallium-based radiopharmaceuticals. Ferreira CL; Lamsa E; Woods M; Duan Y; Fernando P; Bensimon C; Kordos M; Guenther K; Jurek P; Kiefer GE Bioconjug Chem; 2010 Mar; 21(3):531-6. PubMed ID: 20175523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]